Financhill
Sell
49

ADXN Quote, Financials, Valuation and Earnings

Last price:
$7.70
Seasonality move :
34.52%
Day range:
$7.69 - $8.28
52-week range:
$6.51 - $12.05
Dividend yield:
0%
P/E ratio:
0.77x
P/S ratio:
36.54x
P/B ratio:
1.32x
Volume:
3.1K
Avg. volume:
6.1K
1-year change:
2.3%
Market cap:
$9.8M
Revenue:
$465.6K
EPS (TTM):
-$8.44

Earnings Data

Next earnings date for ADXN
Apr 16
2026
Most recent earnings per share
-$2.10
Missed by $2.10
(Dec 4/2025)
Consensus Estimate
--
(Dec 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADXN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/04/2025 Q3 -- $62K -$2.10 -- --
09/25/2025 Q2 -- $44K -$2.66 -- --
03/31/2025 Q1 -- $79K -$2.00 -- --
12/31/2024 Q4 $177.2K $1.7K -$1.68 -- --
09/30/2024 Q3 $130K $67.3K -$2.16 -- --
06/30/2024 Q2 $262.6K $127.4K $10.17 -- --
03/31/2024 Q1 $266.4K $268.7K -$4.34 -- --
12/31/2023 Q4 $717.5K $173.5K -$4.40 -- --
09/30/2023 Q3 $706.5K $372.6K -$4.60 -- --
08/18/2023 Q2 -- $703.1K -$4.95 -- --
03/31/2023 Q1 -- $542.6K -$5.10 -- --
12/31/2022 Q4 -- $621.2K -$7.61 -- --
09/30/2022 Q3 -- $430K -$10.67 -- --
08/18/2022 Q2 -- $193.2K -$23.96 -- --
05/05/2022 Q1 -- $264.1K -$19.96 -- --
03/10/2022 Q4 -- $434.9K -$16.61 -- --
11/01/2021 Q3 -- $746.8K -$13.78 -- --
08/05/2021 Q2 -- $1.1M -$18.15 -- --
05/03/2021 Q1 -- $937.5K -$10.43 -- --
03/08/2021 Q4 -- $2M -$10.52 -- --
11/02/2020 Q3 -- $35.5K -$16.19 -- --
08/12/2020 Q2 -- $899.2K -$14.55 -- --
03/31/2020 Q1 -- $938.2K -$20.06 -- --
12/31/2019 Q4 -- $1.1M -$16.97 -- --
09/30/2019 Q3 -- $509.9K -$17.05 -- --
06/30/2019 Q2 -- $518K -$20.34 -- --
03/31/2019 Q1 -- $703.4K -$14.45 -- --

Addex Therapeutics Ltd. Earnings Questions

  • How Much did Addex Therapeutics Ltd. Generate in Revenue Last Quarter?

    Addex Therapeutics Ltd. reported $62K worth of top line sales in its most recent quarter.

  • Did Addex Therapeutics Ltd. Beat Earnings Last Quarter?

    Addex Therapeutics Ltd. announced earnings per share of -$2.10 which represents a miss of analyst forecast a -- per share.

  • Is Addex Therapeutics Ltd. Profitable?

    Addex Therapeutics Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Addex Therapeutics Ltd. EPS Next Year?

    Addex Therapeutics Ltd.'s earnings are forecast to grow from $5.73 per share to -- per share next year representing an increase of --.

  • When is Addex Therapeutics Ltd.'s Earnings Date?

    Addex Therapeutics Ltd.'s next earnings date is April 16, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock